日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial

认知障碍与绝经前和绝经后妇女的化学内分泌治疗与内分泌治疗:RxPONDER随机临床试验的二次分析

Kang, Irene M; Forschmiedt, Jamie K; Loch, Michelle M; Lew, Danika L; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Rastogi, Priya; Schott, Anne F; Baehner, Rick; Sharma, Priyanka; Tripathy, Debasish; Pusztai, Lajos; Hortobagyi, Gabriel N; Kalinsky, Kevin; Henry, N Lynn

Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

帕博利珠单抗联合比美替尼治疗不可切除的局部晚期或转移性三阴性乳腺癌患者

Chumsri, Saranya; Larson, Joseph J; Liu, Emily; Tenner, Kathleen S; Adams, Daniel; Weidner, Morgan T; Arnold, Amanda N; Haley, Dana L; Advani, Pooja; Sideras, Kostandinos; Moreno-Aspitia, Alvaro; Thompson, E Aubrey; Perez, Edith A; Knutson, Keith L

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

在随机 RxPONDER 试验中,种族与激素受体阳性、HER2 阴性、淋巴结阳性乳腺癌患者的临床结局之间的关系

Abdou, Yara; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Chia, Stephen K L; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suzette; Schott, Anne F; Shak, Steven; Sharma, Priyanka; Lew, Danika L; Miao, Jieling; Unger, Joseph M; Tripathy, Debasish; Hortobagyi, Gabriel N; Pusztai, Lajos; Kalinsky, Kevin

Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer

临床治疗评分5年后(CTS5)与激素受体阳性、HER2阳性乳腺癌的晚期复发风险

Chumsri, Saranya; Pai, Tanmayi; Ma, Yaohua; Li, Zhuo; Gil, Angelica; Moreno-Aspitia, Alvaro; Colon-Otero, Gerardo; Pogue-Geile, Katherine L; Rasgoti, Priya; Paik, Soonmyung; Perez, Edith A; Thompson, E Aubrey

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗(有或无贝伐珠单抗)的随机 III 期双盲安慰剂对照试验:ECOG-ACRIN 癌症研究组 (E1105) 的一项试验

Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗(有或无贝伐珠单抗)的随机 III 期双盲安慰剂对照试验:ECOG-ACRIN 癌症研究组的一项试验 (E1105)

Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.

不同的空间免疫微环境与三阴性乳腺癌的预后独立相关

Carter Jodi M, Chumsri Saranya, Hinerfeld Douglas A, Ma Yaohua, Wang Xue, Zahrieh David, Hillman David W, Tenner Kathleen S, Kachergus Jennifer M, Brauer Heather Ann, Warren Sarah E, Henderson David, Shi Ji, Liu Yi, Joensuu Heikki, Lindman Henrik, Leon-Ferre Roberto A, Boughey Judy C, Liu Minetta C, Ingle James N, Kalari Krishna R, Couch Fergus J, Knutson Keith L, Goetz Matthew P, Perez Edith A, Thompson E Aubrey

Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival

年龄、体重指数、肿瘤亚型以及种族和民族差异对乳腺癌生存率的影响

Lipsyc-Sharf, Marla; Ballman, Karla V; Campbell, Jordan D; Muss, Hyman B; Perez, Edith A; Shulman, Lawrence N; Carey, Lisa A; Partridge, Ann H; Warner, Erica T

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

在辅助性 NSABP B-31 临床试验中重复验证化疗相关心脏毒性的遗传关联

Advani, Pooja P; Ruddy, Kathryn J; Herrmann, Joerg; Ray, Jordan C; Craver, Emily C; Yothers, Greg; Cecchini, Reena S; Lipchik, Corey; Feng, Huichen; Rastogi, Priya; Mamounas, Eleftherios P; Swain, Sandra M; Geyer, Charles E Jr; Wolmark, Norman; Paik, Soonmyung; Pogue-Geile, Katherine L; Colon-Otero, Gerardo; Perez, Edith A; Norton, Nadine

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

NCCTG(Alliance)N9831 和 NeoALTTO 试验中 HER2 阳性乳腺癌的适应性免疫特征

Chumsri, Saranya; Li, Zhuo; Serie, Daniel J; Norton, Nadine; Mashadi-Hossein, Afshin; Tenner, Kathleen; Brauer, Heather Ann; Warren, Sarah; Danaher, Patrick; Colon-Otero, Gerardo; Partridge, Ann H; Carey, Lisa A; Hilbers, Florentine; Van Dooren, Veerle; Holmes, Eileen; Di Cosimo, Serena; Werner, Olena; Huober, Jens Bodo; Dueck, Amylou C; Sotiriou, Christos; Saura, Cristina; Moreno-Aspitia, Alvaro; Knutson, Keith L; Perez, Edith A; Thompson, E Aubrey